Small Cell Lung Cancer (SCLC) Latest Advances

Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer  Based on Molecular Subtyping

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: September 07, 2026

Oral urea in paraneoplastic syndrome of inadequate antidiuretic hormone secretion due to small-cell carcinoma ‒ Sustained, safe, and cost-effective correction through outpatient management

Journal: Nutricion hospitalaria

Published: September 07, 2026

Advances in Systemic Therapy for Extensive-stage Small Cell Lung Cancer  in the Era of Precision Treatment

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: September 07, 2026

Key barriers in utilizing advanced T-cell engager strategies on solid tumors.

Journal: Expert review of anticancer therapy

Published: September 07, 2026

Corrigendum to "EML4-ALK fusion in small cell lung cancer: clinical and molecular insights from a rare case" [Lung Cancer 202 (2025) 108497].

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 04, 2026

Cerebellar Degeneration Causing Saccadic Dysmetria and Ocular Flutter: A Seronegative Paraneoplastic Syndrome.

Journal: Neuro-ophthalmology (Aeolus Press)

Published: September 04, 2026

Corrigendum to "Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer" [Cancer Lett. 592, (2024), 216929].

Journal: Cancer letters

Published: August 28, 2026

Targeting ErbB-Family Receptors in Small Cell Lung Cancer: Clinical Activity and an Unresolved Mechanism.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 27, 2026

The role of FGFR signaling in SCLC and NSCLC: Current insights and therapeutic perspectives.

Journal: iScience

Published: August 20, 2026

Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Early Induction of IVIg Improved the Performance Status and Enabled Chemotherapy Initiation in PCD-LEMS: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: August 19, 2026

Polycomb Scaffolding Subunit EED Supports the SCLC Neuroendocrine Identity and EGFR-Mutant LUAD to SCLC Transformation.

Journal: The Journal of clinical investigation

Published: August 18, 2026

Small Cell Lung Cancer (SCLC) Latest Advances

Find the Latest Research About Small Cell Lung Cancer (SCLC)

Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer Based on Molecular Subtyping

Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer Based on Molecular Subtyping

Oral urea in paraneoplastic syndrome of inadequate antidiuretic hormone secretion due to small-cell carcinoma ‒ Sustained, safe, and cost-effective correction through outpatient management

Oral urea in paraneoplastic syndrome of inadequate antidiuretic hormone secretion due to small-cell carcinoma ‒ Sustained, safe, and cost-effective correction through outpatient management

Advances in Systemic Therapy for Extensive-stage Small Cell Lung Cancer in the Era of Precision Treatment

Advances in Systemic Therapy for Extensive-stage Small Cell Lung Cancer in the Era of Precision Treatment

Key barriers in utilizing advanced T-cell engager strategies on solid tumors.

Key barriers in utilizing advanced T-cell engager strategies on solid tumors.

Corrigendum to "EML4-ALK fusion in small cell lung cancer: clinical and molecular insights from a rare case" [Lung Cancer 202 (2025) 108497].

Corrigendum to "EML4-ALK fusion in small cell lung cancer: clinical and molecular insights from a rare case" [Lung Cancer 202 (2025) 108497].

Cerebellar Degeneration Causing Saccadic Dysmetria and Ocular Flutter: A Seronegative Paraneoplastic Syndrome.

Cerebellar Degeneration Causing Saccadic Dysmetria and Ocular Flutter: A Seronegative Paraneoplastic Syndrome.

Corrigendum to "Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer" [Cancer Lett. 592, (2024), 216929].

Corrigendum to "Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer" [Cancer Lett. 592, (2024), 216929].

Targeting ErbB-Family Receptors in Small Cell Lung Cancer: Clinical Activity and an Unresolved Mechanism.

Targeting ErbB-Family Receptors in Small Cell Lung Cancer: Clinical Activity and an Unresolved Mechanism.

The role of FGFR signaling in SCLC and NSCLC: Current insights and therapeutic perspectives.

The role of FGFR signaling in SCLC and NSCLC: Current insights and therapeutic perspectives.

Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer.

Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer.

Early Induction of IVIg Improved the Performance Status and Enabled Chemotherapy Initiation in PCD-LEMS: A Case Report.

Early Induction of IVIg Improved the Performance Status and Enabled Chemotherapy Initiation in PCD-LEMS: A Case Report.

Polycomb Scaffolding Subunit EED Supports the SCLC Neuroendocrine Identity and EGFR-Mutant LUAD to SCLC Transformation.

Polycomb Scaffolding Subunit EED Supports the SCLC Neuroendocrine Identity and EGFR-Mutant LUAD to SCLC Transformation.

Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer  Based on Molecular Subtyping

Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer  Based on Molecular Subtyping

Advances in Systemic Therapy for Extensive-stage Small Cell Lung Cancer  in the Era of Precision Treatment

Advances in Systemic Therapy for Extensive-stage Small Cell Lung Cancer  in the Era of Precision Treatment